San Carlo Clinic, Paderno Dugnano, Milano, Italy.
University of Parma, Parma, Italy.
Int J Low Extrem Wounds. 2020 Dec;19(4):293-304. doi: 10.1177/1534734620954745. Epub 2020 Sep 11.
In the last 15 years an abundance of literature has demonstrated that angiosome-targeted revascularization, either endovascular or open, can lead to better clinical results in patients with chronic limb-threatening ischemia. According to this literature, the angiosome concept should guide our treatment strategy in every chronic limb-threatening ischemia patient. However, in our daily practice, its application is often difficult or impossible. Most foot wounds spread over multiple angiosomes and, moreover, the value of an angiosome-guided revascularization approach can vary according to vascular anatomy, collateral vessel network, type of revascularization, and wound. The aim of this article is to explore values and limits of the angiosome concept, and to propose some "instructions for use" regarding its application in our daily practice.
在过去的 15 年中，大量文献表明，针对血管生成体的血运重建（无论是血管内还是开放性的）可以为慢性肢体威胁性缺血患者带来更好的临床结果。根据这些文献，血管生成体概念应该指导我们对每一位慢性肢体威胁性缺血患者的治疗策略。然而，在我们的日常实践中，它的应用往往是困难的或不可能的。大多数足部伤口跨越多个血管生成体，而且，血管生成体指导的血运重建方法的价值可能因血管解剖、侧支血管网络、血运重建类型和伤口类型而有所不同。本文旨在探讨血管生成体概念的价值和局限性，并提出一些在日常实践中应用它的“使用说明”。
